Cited by 80Lipoproteins and Cardiovascular HealthLipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias.

de Graaf, Jacqueline, Couture, Patrick, Sniderman, Allan·2008·Nature Clinical Practice Endocrinology & Metabolism

Abstract

Given the high prevalence of the atherogenic forms of apolipoprotein B (apoB) dyslipoproteinemias and the effectiveness of appropriate therapy, we feel that access for all physicians to simple, effective diagnostic aids that enable use of widely available technology is vitally important in clinical lipidology. In this Review, therefore, we present a diagnostic algorithm for the diagnosis of these disorders that is based on concentrations of total cholesterol, triglyceride and apoB. By including apoB values, lipoprotein number and composition can be deduced and each of the classic dyslipoproteinemias identified. All three parameters can be accurately and inexpensively determined in clinical laboratories and, therefore, this algorithm can be used by any physician to make an accurate diagnosis without use of specialist research laboratories. Just as the application of LDL cholesterol measurement moved clinical practice forward from plasma lipids to lipoprotein lipids, we believe that the use of apoB will further advance diagnosis and treatment of dyslipoproteinemias.

Integrity signals

Registry

Crossref · 10.1038/ncpendmet0982

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 67 · Cited by 80

Authors
de Graaf, J., Couture, P., & Sniderman, A.
Affiliations
  • Université Laval (CA)
  • McGill University (CA)
Corresponding author
Sniderman, Allan
Venue
Nature Clinical Practice Endocrinology & Metabolism
Published
2008-10-07
Volume
4
Issue
11
Pages
608-618
ISSN
  • 1745-8366 (ISSN-L)
  • 1745-8374
OpenAlex
W2135142672
Cited by
80
References
67
Citations by year
2026: 1 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 8 · 2021: 3 · 2020: 5 · 2019: 1 · 2018: 8 · 2017: 5 · 2015: 2 · 2014: 3 · 2013: 7 · 2012: 4
FWCI
1.31
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Clinical Practice Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
apolipoprotein B, dyslipoproteinemia, diagnostic algorithm, total cholesterol, triglycerides, lipoprotein composition, clinical lipidology
MeSH terms
Algorithms, Apolipoproteins B, Humans, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review